Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis

BACKGROUND: Paclitaxel dose-dense regimen has been controversial in clinical trials in recent years. This systematic review and meta-analysis tried to evaluate the efficacy and safety of paclitaxel dose-dense chemotherapy in primary epithelial ovarian cancer. METHODS: An electronic search following...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Wenjian, Yu, Ruidi, Cao, Canhui, Fang, Yong, Zhao, Xuejiao, Gao, Qinglei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331960/
https://www.ncbi.nlm.nih.gov/pubmed/37430376
http://dx.doi.org/10.1186/s13048-023-01216-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331960/
https://www.ncbi.nlm.nih.gov/pubmed/37430376
http://dx.doi.org/10.1186/s13048-023-01216-z

Ejemplares similares